title: Microangiopathic hemolytic anemia secondary to cyclosporine therapy in a heart and liver transplant recipient.
authors.forename: J F
authors.initials: JF
authors.lastname: Oteo
authors.forename: L
authors.initials: L
authors.lastname: Alonso-Pulpón
authors.forename: J L
authors.initials: JL
authors.lastname: Diez
authors.forename: C
authors.initials: C
authors.lastname: Camacho
authors.forename: C
authors.initials: C
authors.lastname: Expósito
authors.forename: A
authors.initials: A
authors.lastname: González
authors.forename: S
authors.initials: S
authors.lastname: Serrano-Fiz
mesh_terms: D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000473:pathology; D002196:Capillaries / Q000473:pathology; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D016027:Heart Transplantation / Q000473:pathology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016031:Liver Transplantation / Q000473:pathology*; D008297:Male; D010488:Polyarteritis Nodosa / Q000139:chemically induced* / Q000473:pathology; D011183:Postoperative Complications / Q000139:chemically induced* / Q000473:pathology; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000473:pathology; D012867:Skin / Q000098:blood supply
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine